Study Shows Purdue’s Switch to ‘Abuse-Deterrent’ OxyContin Helped Drive a Spike in Hepatitis C Infections

February 5, 2019

(STAT News) – When Purdue Pharma reformulated its signature pain drug OxyContin in 2010, its aim was to make the pill “abuse-deterrent.” But the change may have had an unanticipated and disastrous public health impact, according to a new study: accelerating a nationwide spike in hepatitis C infections. When the new version of OxyContin became far more difficult to crush or ingest nasally, many opioid users switched to injecting illicit heroin after 2010. That shift, researchers found, caused hepatitis C rates to spike three times faster in states with the highest non-medical OxyContin use.

Recommended Reading